Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi, India.
Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi, India.
Diabetes Res Clin Pract. 2023 Oct;204:110893. doi: 10.1016/j.diabres.2023.110893. Epub 2023 Aug 31.
To study, the incidence and risk factors for postpartum diabetes (DM), in women with gestational diabetes mellitus (GDM) from South Asia (Bangladesh, India and Sri Lanka), followed for nearly two years after delivery.
Women with prior GDM diagnosed using IADPSG criteria were invited at 19 centres across Bangladesh, India and Sri Lanka for an oral glucose tolerance test (OGTT) following childbirth, and were enrolled in a randomized controlled trial. The glycaemic category (outcome) was defined from an OGTT based on American Diabetes Association criteria.
Participants (n = 1808) recruited had a mean ± SD age of 31.0 ± 5.0 years. Incident DM was identified, between childbirth and the last follow-up, in 310 (17.1 %) women [incidence 10.75/100 person years], with a median follow-up duration of 1.82 years after childbirth. Higher age, lower education status, higher prior pregnancy count, prior history of GDM, family history of DM, and postpartum overweight/obese status were significantly associated with incident DM. Women in Bangladesh had a higher cumulative incidence of DM [16.49/100 person years] than in Sri Lanka [12.74/100 person years] and India [7.21/100 person years].
A high incidence of DM was found in women with prior GDM in South Asia, with significant variation between countries. Women from Bangladesh had a significantly higher pregnancy count, family history of DM and overweight/obese status, despite having significantly lower age, which could be responsible for their higher rates of DM. Registration of this study: The study was registered with the Clinical Trials Registry of India (CTRI/2017/06/008744), Sri Lanka Clinical Trials Registry (SLCTR/2017/001), and ClinicalTrials.gov (NCT03305939).
研究南亚(孟加拉国、印度和斯里兰卡)的妊娠糖尿病(GDM)女性在产后近 2 年内发生糖尿病(DM)的发病率和危险因素。
在孟加拉国、印度和斯里兰卡的 19 个中心,邀请既往符合 IADPSG 标准诊断的 GDM 女性在产后进行口服葡萄糖耐量试验(OGTT),并参与一项随机对照试验。根据美国糖尿病协会标准,基于 OGTT 结果来定义血糖类别(结局)。
共招募了 1808 名参与者,其平均年龄±标准差为 31.0±5.0 岁。在产后和最后一次随访之间,310 名(17.1%)女性确诊为 DM[发病率为 10.75/100 人年],产后随访中位数为 1.82 年。较高的年龄、较低的教育程度、较高的既往妊娠次数、既往 GDM 史、糖尿病家族史和产后超重/肥胖状态与 DM 发病显著相关。孟加拉国女性的 DM 累积发病率[16.49/100 人年]高于斯里兰卡[12.74/100 人年]和印度[7.21/100 人年]。
南亚 GDM 女性的 DM 发病率较高,且各国之间存在显著差异。尽管孟加拉国女性的年龄明显较小,但她们的妊娠次数、糖尿病家族史和超重/肥胖状态显著更高,这可能是导致其 DM 发病率较高的原因。本研究在印度临床试验注册中心(CTRI/2017/06/008744)、斯里兰卡临床试验注册中心(SLCTR/2017/001)和 ClinicalTrials.gov(NCT03305939)进行了注册。